OrthoD is a specialist manufacturer and distributor of medical products and implants for joint reconstruction, sport medicine, surgical products and infection control applications. Created in 1984, the company has distribution channels in over 50 countries worldwide.


A growing aging population with conditions such as osteoarthritis combined with an increase in obesity will continue drive demand for joint reconstruction and sport medicines solutions. Quality is a key value for OrthoD which has constant focus on control and conformity to assure safety and performance of its products and ultimately to contribute to the success of the procedure and improved patient outcomes.

Investment Rationale

OrthoD is a solid business which has built longstanding relationships and a strong reputation with its customers. Apposite Capital sees significant potential in supporting management in further building OrthoD’s export channels and in commercialising the sport medicine products portfolio.